AzTrials
AzTrials

Reading DisabilityNCT05523505

Noninvasive Brain Stimulation to Enhance Reading Comprehension Ability in Adults

A study testing RLN real non-invasive brain stimulation intervention and RLN and CCN real non-invasive brain stimulation intervention in people with Reading Disability, run by Vanderbilt University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this project is to address the urgent need for effective, scalable adult literacy interventions by integrating breakthroughs in two separate fields: 1.) the brain network science of resilience to reading disorders and 2.) high-definition non-invasive brain network stimulation. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Reading Disability
What is being tested?
RLN real non-invasive brain stimulation intervention and RLN and CCN real non-invasive brain stimulation intervention
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteUnited States
Study dates
7 Nov 2022to 1 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • This study will be open to all right-handed, native English monolingual speakers, who meet eligibility criteria regardless of race, gender, minority or socioeconomic status. Due to age-related differences in the language and learning processes, the age range of subjects will be a minimum of 18 years and a maximum of 40 years.

Who cannot join

  • We will exclude individuals with a personal medical history of stroke or seizures or those taking medications specifically prescribed for the treatment of stroke or seizures. However, participants who are on medications that carry an associated risk of stroke or seizures but are not prescribed for these conditions (e.g., anticonvulsants prescribed for pain or behavioral reasons) will remain eligible. Exclusion criteria will be determined by follow-up telephone screenings conducted by lab KSP and is as follows:
  • previous diagnosis of Intellectual Disability;
  • known uncorrectable visual impairment;
  • documented hearing impairment greater than or equal to a 25 dB loss;
  • medical contraindication to MRI procedures (e.g., metal devices);
  • known IQ below 70;
Show all 17Show fewer
  • a pervasive developmental disorder;
  • any known neurologic pathology, including epilepsy, spina bifida, cerebral palsy, traumatic brain injury, and brain tumors;
  • recent medical diagnosis of migraines;
  • pregnancy;
  • history of syncope;
  • severe fatigue,
  • bilingualism or low English proficiency;
  • poor reading ability that will prevent completion of the tasks; and
  • comorbid severe psychiatric disorders will be excluded;
  • a personal medical history of stroke or seizures;
  • hair styles that do not allow for proper EEG net fitting, or that pose potential risks for damage to EEG net

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203

Other trials in United States

About this study

Official title: Bridging the Gap Between Brain Network Science and High-definition Non-invasive Brain Stimulation to Develop a Scalable Adult Literacy Intervention

The goal of this project is to address the urgent need for effective, scalable adult literacy interventions by integrating breakthroughs in two separate fields: 1.) the brain network science of resilience to reading disorders and 2.) high-definition non-invasive brain network stimulation. This study will first establish the efficacy of a novel, noninvasive stimulation protocol on reading behavior and brain metrics; then will determine how stimulation-induced effects interact with baseline reading comprehension ability; and lastly, will identify whether stimulation-induced effects are more clinically-beneficial than canonical behavioral interventions. Results may change the foundation for how we treat low adult literacy, and have the potential for wider reaching impacts on non-invasive stimulation protocols for other clinical disorders.

Read the detailed description

One in five adults in the US are unable to adequately comprehend a sentence. Low literacy is a major public health crisis, with no existing solution: findings from the Programme for the International Assessment of Adult Competencies (PIAAC) reveal that there have been no significant improvements to US national statistics on literacy in the past 30 years. Studies of the survey data reveal that adults with low literacy in the US have in-tact but slow word reading processes and vocabulary, and struggle to comprehend sentences and passages. Rates of poor reading comprehension (RC) ability are especially alarming given that RC ability is strongly predictive of educational outcomes, occupation and wage, health literacy/outcomes, and crime. Through these links, the World Literacy Foundation estimates that the literacy crisis accounts for 2% of the US's GDP annually. The current gold-standard interventions for RC ability are behavioral interventions that focus on cognitive skills found to support RC. However, meta-analyses across interventions show minimal raw gains. Brain research has allowed for the identification of "hidden" RC processes that are not captured by behavioral tests These studies have identified a consistent brain pathway that supports positive RC outcomes. This pathway is a compelling target for brain-based interventions. In particular, recent advances in noninvasive brain stimulation interventions provide a promising route for clinically-meaningful, brain-based treatments. However, brain research in RC has not been translated into an effective brain-based intervention. There is an urgent need for a cutting-edge, non-invasive brain stimulation intervention that will transform the way we approach the clinical treatment of poor RC. The current project will integrate our work in the brain network science of RC and breakthroughs in non-invasive stimulation to address these challenges and develop a brain-based RC intervention.

To accomplish this, the proposed study will invite typical adults with a range of RC ability (good and poor) to participate in three visits to the lab. The rationale for examining adults is to that the current study aims to develop a brain-based intervention (i.e. non-invasive brain stimulation) to treat low literacy in adults, as current behavioral interventions in adults are largely unsuccessful. N=100 participants will come in for three visits; for each visit adults will complete behavioral testing, magnet resonance imaging (MRI), and electroencephalography (EEG). Visit 1 will establish baseline behavior and brain measures of the individual (total visit time of 3.5 hours). Visit 2 will include a behavioral and safe, non-invasive stimulation intervention for the individual (total visit of 3 hours). Stimulation will involve two sessions, one while subjects are in the MRI, and one while subjects are having EEG. Visit 2 will also involve behavioral testing to determine intervention effects. Visit 3 will establish prolonged intervention effects using behavior and brain measures of the individual (total visit of 2.5 hours). Participants will be recruited and randomly assigned to receive one of three non-invasive stimulation interventions, and all will receive a canonical behavioral intervention, so that the smallest subgroup in the study will be N=30, which provides sufficient statistical power (see Statistical Design and Power). All subjects will have typical word reading ability (greater than or equal to 15th percentile), and either good (greater than 25th percentile) or poor (less than or equal to 25th percentile) reading comprehension ability. Non-invasive stimulation subgroups include two stimulation groups distinguished only by electrode placement, and one sham control group. Behavioral intervention involves a short paper/pencil reading comprehension intervention. Each intervention subgroup will be randomly assigned, but with the restriction that the distribution of reading comprehension ability is even across subgroups. This will be accomplished while maintaining double-blind procedures. Collection will begin in Summer 2022 and continue through Fall 2026. Adults will be recruited from the Nashville community. Behavioral testing and MRI (with and without stimulation) will occur at the Vanderbilt Institute for Imaging Science (VUIIS). EEG (with and without stimulation) will occur at the Vanderbilt Kennedy Center.

Being tested
Sham intervention, RLN real non-invasive brain stimulation intervention, RLN and CCN real non-invasive brain stimulation intervention
Keywords
Neuroimaging, Adults, Non-invasive Brain Stimulation, Reading, Reading Comprehension
Medical subject headings
Dyslexia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sham interventionDevice

    Use of the non-invasive brain stimulation device to simulate peripheral experience of stimulation without actually stimulating the brain.

  • RLN real non-invasive brain stimulation interventionDevice

    Real non-invasive brain stimulation to the left angular gyrus using transcranial alternating current stimulation (tACS).

  • RLN and CCN real non-invasive brain stimulation interventionDevice

    Real non-invasive brain stimulation to the left dorsolateral prefrontal cortex and left angular gyrus using transcranial alternating current stimulation (tACS).

Study groups in NCT05523505
Study groupRoleWhat they receive
Sham stimulationSham comparatorParticipants receiving sham stimulation.
Receives: Device: Sham intervention
Reading and Language Network (RLN)ExperimentalParticipants receiving real stimulation to the left angular gyrus.
Receives: Device: RLN real non-invasive brain stimulation intervention
RLN and CCNExperimentalParticipants receiving real stimulation to the left dorsolateral prefrontal cortex and left angular gyrus.
Receives: Device: RLN and CCN real non-invasive brain stimulation intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in reading comprehension ability on standardized test measure

    Stimulation induced change in reading comprehension ability measured by Gates MacGinitie Reading Test:

    • Reading Comprehension Subtest (Adult Reader; AR): Participants have 35 minutes to read passages and answer 48 comprehension questions about what they read.
    • Percentile Ranks based on the scores of entering community college students
    • Primary outcome measure is the change in percentile ranks

    Measured: Baseline to 12 months

  2. Performance in reading comprehension ability on test measure during stimulation session

    Stimulation induced performance in reading comprehension ability measured by free recall of information learned while reading during stimulation session.

    • Subject asks to recall content from 100 total sentences
    • Primary outcome measure is the number correct out of total (# recalled / total) compared across groups (real stimulation subgroups and sham).

    Measured: Baseline to 12 months

Secondary outcomes (1)
  1. Change in brain activations during reading

    Stimulation induced change in brain activations during reading as measured by a joint analysis of functional magnetic resonance imaging and electroencephalography.

    • Measures of co-activation in brain areas are obtained for certain timepoints during sentence reading.
    • Typical brain patterns over time are obtained from readers without reading difficulties.
    • The primary outcome measure is a weighting value that reflects how strongly a subject's brain signals align with expected brain signals for typical reading processes.

    Measured: Baseline to 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2022
  2. Study start7 Nov 2022
  3. Primary completion1 Aug 2026
  4. Study completion1 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05523505
Sponsor's protocol ID
220596
Other IDs
DP5OD031843
Status last verified
Oct 2026
First submitted
17 Aug 2022
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: All research resources and other information developed in this project will be made readily available to the scientific community to support replication of the study's research findings as well as big-data initiatives. Anonymized raw neuroimaging data, demographic data (including age, sex, ethnicity, handedness, and socioeconomic status), and neuroimaging collection parameters will be deposited in the open source data base, NITRC (NeuroImaging Tools and Resources Collaboratory). This will be made publicly available within six months of the initial publication of the data, which we anticipate will occur in year 5 of the proposed research. Other mechanisms for the transfer of information, including research findings and relevant code, will take the form of peer-reviewed publications with links to open source code, posters at scientific conferences and research presentations.

Questions about this trial

What is this clinical trial studying?

A study testing RLN real non-invasive brain stimulation intervention and RLN and CCN real non-invasive brain stimulation intervention in people with Reading Disability, run by Vanderbilt University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in reading comprehension ability on standardized test measure (time frame: Baseline to 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in